Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #651 to #700.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. DETAIL → Diabetics Exposed To Telmisartan And Enalapril
  2. DASH → Dietary Approaches To Stop Hypertension
  3. DIAGNOSIS → Diffusion-Weighted Imaging Assessment Of The Genuine Need For Other Studies In Ischemic Stroke
  4. DEFUSE → Diffusion-Weighted Imaging Evaluation For Understanding Stroke Evaluation
  5. DMIST → Digital Mammographic Imaging Screening Trial
  6. DIG → Digoxin Investigation Group
  7. DART → Dilation Versus Ablation Revascularization Trial
  8. Suction curettage → Dilation and curettage
  9. D and C → Dilation and curettage
  10. D&C → Dilation and curettage
  11. Uterine scraping → Dilation and curettage
  12. DIDI → Diltiazem In Dilated Cardiomyopathy
  13. Dmitry Ivanovsky → Dimitri Ivanovski
  14. Dionne Quintuplets → Dionne quintuplets
  15. DISCO → Direct Coronary Stenting Versus Stenting With Balloon Predilation: Immediate And Follow-Up Results
  16. DELTA MI → Direct Inhibition Of Δ-Protein Kinase C Enzyme To Limit Total Infarct Size In Acute Mi
  17. DIRECTOR → Direct Stenting Study With Orbus R Stent
  18. Circular statistics → Directional statistics
  19. DISC → Disability In Strategies For Care
  20. Disassortative sexual selection → Disassortative mating
  21. Emergency Locator Transmitter → Distress radiobeacon
  22. Emergency Position-Indicating Radio Beacon → Distress radiobeacon
  23. Personal Locator Beacon → Distress radiobeacon
  24. CABG Patch Cardioplegia Substudy → Does Cardioplegia Type Affect Outcome And Survival In Patients With Advanced Left Ventricular Dysfunction? Results From The Cabg Patch Tria
  25. Doggy position → Doggy style
  26. Domination & submission (BDSM) → Dominance and submission
  27. DEBATE → Doppler Endpoints Balloon Angioplasty Trial Europe
  28. DEBATE II → Doppler Endpoints Balloon Angioplasty Trial Europe-2
  29. DESTINI-CFR → Doppler Endpoints Stenting International Investigation - Coronary Flow Reserve
  30. PRECISE → Double-Blind, Placebo-Controlled Study Of The Effects Of Carvedilol In Patients With Moderate To Severe Heart Failure
  31. REFLECT → Double-Blind, Placebo-Controlled Study Of The Efficacy Of Flosequinan In Patients With Chronic Heart Failure
  32. SUTAMI → Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
  33. DIMT → Double-Blind Placebo-Controlled Study Of Ibopamine And Digoxin In Patients With Mild To Moderate Heart Failure: Results Of The Dutch Ibopamine Multic
  34. SAPAT → Double-Blind Trial Of Aspirin In Primary Prevention Of Myocardial Infarction In Patients With Stable Chronic Angina Pectoris
  35. Dow Chemical → Dow Chemical Company
  36. Dr. Reddy's → Dr. Reddy's Laboratories
  37. DECLARE-DIABETES → Drug-Eluting Stenting Followed By Cilostazol Treatment Reduces Late Restenosis In Patients With Diabetes Mellitus
  38. ISAR-DESIRE → Drug-Eluting Stents For In-Stent Restenosis
  39. DEDICATION: Stent Study → Drug Elution And Distal Protection In Acute Myocardial Infarction
  40. DEDICATION: Distal Protection Study → Drug Elution And Distal Protection In St-Elevation Myocardial Infarction
  41. Drug Enforcement Agency → Drug Enforcement Administration
  42. United States Drug Enforcement Administration → Drug Enforcement Administration
  43. DAVID – (Picotamide vs. Aspirin) → Drug Evaluation In Atherosclerotic Vascular Disease In Diabetics
  44. Drug policy → Drug policy of the United States
  45. DAVID → Dual-Chamber And Vvi Implantable Defibrillator
  46. DAVID II → Dual Chamber And Vvi Implantable Defibrillator II
  47. DAPPAF → Dual Site Atrial Pacing To Prevent Atrial Fibrillation
  48. DUCCS-1 → Duke University Clinical Cardiology Study - 1
  49. DUCCS-2 → Duke University Clinical Cardiology Study - 2
  50. DECREASE-V → Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-V

View ( | ) (20 | 50 | 100 | 250 | 500)